Skip to main content
SpringerLink
Log in

Central Retinal Vein Occlusion

  • Chapter
  • First Online:
Retinal Vascular Disease

Part of the book series: Retina Atlas ((RA))

  • 585 Accesses

Abstract

As descriptively named as it is, central retinal vein occlusions (CRVO) are often misunderstood. In a CRVO, return of the venous circulation is relatively reduced by an obstruction. The obstruction itself is poorly understood due to our lack of ability to adequately visualize it, but is potentially compressive, inflammatory, thrombotic, or vasospastic. Histopathologic studies have demonstrated a thrombus at or proximal to the lamina cribrosa (Green et al. 1981), suggesting anatomic variations may be important.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480–7.

    CAS  PubMed  Google Scholar 

  • Arakawa S, Yasuda M, Nagata M, Ninomiya T, Hirakawa Y, Doi Y, et al. Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci. 2011;52(8):5905–9.

    PubMed  Google Scholar 

  • Arevalo JF, Garcia RA, Wu L, Rodriguez FJ, Dalma-Weiszhausz J, Quiroz-Mercado H, et al. Radial optic neurotomy for central retinal vein occlusion: results of the pan-American collaborative retina study group (PACORES). Retina. 2008;28(8):1044–52.

    PubMed  Google Scholar 

  • Brown GC, Duker JS, Lehman R, Eagle RC Jr. Combined central retinal artery-central vein obstruction. Int Ophthalmol. 1993;17(1):9–17.

    CAS  PubMed  Google Scholar 

  • Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117(6):1124–33.e1.

    PubMed  Google Scholar 

  • Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology. 2011;118(10):2041–9.

    PubMed  Google Scholar 

  • Campochiaro PA, Hafiz G, Mir TA, Scott AW, Solomon S, Zimmer-Galler I, et al. Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial. Ophthalmology. 2015;122(7):1426–37.

    PubMed  Google Scholar 

  • Chou KT, Huang CC, Tsai DC, Chen YM, Perng DW, Shiao GM, et al. Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese. Am J Ophthalmol. 2012;154(1):200–5.e1.

    PubMed  Google Scholar 

  • Ehlers JP, Decroos FC, Fekrat S. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina. 2011;31(9):1856–62.

    CAS  PubMed  Google Scholar 

  • Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064–77.e35.

    PubMed  Google Scholar 

  • Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A. Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. Ophthalmology. 2012;119(12):2587–91.

    PubMed  Google Scholar 

  • Fekrat S, de Juan E Jr. Chorioretinal venous anastomosis for central retinal vein occlusion: transvitreal venipuncture. Ophthalmic Surg Lasers. 1999;30(1):52–5.

    CAS  PubMed  Google Scholar 

  • Feltgen N, Junker B, Agostini H, Hansen LL. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology. 2007;114(4):716–23.

    PubMed  Google Scholar 

  • Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993;37(6):393–417.

    CAS  PubMed  Google Scholar 

  • Funk M, Kriechbaum K, Prager F, Benesch T, Georgopoulos M, Zlabinger GJ, et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci. 2009;50(3):1025–32.

    PubMed  Google Scholar 

  • Glacet-Bernard A, Leroux les Jardins G, Lasry S, Coscas G, Soubrane G, Souied E, et al. Obstructive sleep apnea among patients with retinal vein occlusion. Arch Ophthalmol. 2010;128(12):1533–8.

    PubMed  Google Scholar 

  • Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina. 1981;1(1):27–55.

    CAS  PubMed  Google Scholar 

  • Gutman FA. Evaluation of a patient with central retinal vein occlusion. Ophthalmology. 1983;90(5):481–3.

    CAS  PubMed  Google Scholar 

  • Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117(6):1134–46.e3.

    PubMed  Google Scholar 

  • Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res. 2005;24(4):493–519.

    PubMed  Google Scholar 

  • Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117(4):429–41.

    CAS  PubMed  Google Scholar 

  • Hayreh SS, Zimmerman MB, Beri M, Podhajsky P. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion. Ophthalmology. 2004;111(1):133–41.

    PubMed  Google Scholar 

  • Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology. 2011;118(1):119–33.e1–2.

    PubMed  Google Scholar 

  • Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012;119(4):802–9.

    PubMed  Google Scholar 

  • Heier JS, Clark WL, Boyer DS, Brown DM, Vitti R, Berliner AJ, et al. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study. Ophthalmology. 2014;121(7):1414–20.e1.

    PubMed  Google Scholar 

  • Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142(6):1054–6.

    CAS  PubMed  Google Scholar 

  • Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the beaver dam eye study. Trans Am Ophthalmol Soc. 2000;98:133–41. discussion 41–3.

    Google Scholar 

  • Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the beaver dam eye study. Arch Ophthalmol. 2008;126(4):513–8.

    PubMed  Google Scholar 

  • Korobelnik JF, Holz FG, Roider J, Ogura Y, Simader C, Schmidt-Erfurth U, et al. Intravitreal Aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study. Ophthalmology. 2014;121(1):202–8.

    PubMed  Google Scholar 

  • Lahey JM, Tunc M, Kearney J, Modlinski B, Koo H, Johnson RN, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology. 2002;109(1):126–31.

    PubMed  Google Scholar 

  • Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina. 2007;27(4):426–31.

    PubMed  Google Scholar 

  • McAllister IL, Gillies ME, Smithies LA, Rochtchina E, Harper CA, Daniell MD, et al. The central retinal vein bypass study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology. 2010;117(5):954–65.

    PubMed  Google Scholar 

  • Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains eye study. Arch Ophthalmol. 1996;114(10):1243–7.

    CAS  PubMed  Google Scholar 

  • CVOS. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The central vein occlusion study group N report. Ophthalmology. 1995a;102(10):1434–44.

    Google Scholar 

  • CVOS. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The central vein occlusion study group M report. Ophthalmology. 1995b;102(10):1425–33.

    Google Scholar 

  • Eye Disease Case-Control Study. Risk factors for central retinal vein occlusion. The eye disease case-control study group. Arch Ophthalmol. 1996;114(5):545–54.

    Google Scholar 

  • CVOS. Natural history and clinical management of central retinal vein occlusion. The central vein occlusion study group. Arch Ophthalmol. 1997;115(4):486–91.

    Google Scholar 

  • O’Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008;126(5):692–9.

    PubMed  Google Scholar 

  • Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117(2):313–9.e1.

    PubMed  Google Scholar 

  • Russo V, Barone A, Conte E, Prascina F, Stella A, Noci ND. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina. 2009;29(4):511–5.

    PubMed  Google Scholar 

  • Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol. 2009;127(9):1115–28.

    PubMed  PubMed Central  Google Scholar 

  • Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, et al. Effect of Bevacizumab vs Aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the SCORE2 randomized clinical trial. JAMA. 2017;317(20):2072–87.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Spaide RF. Peripheral areas of nonperfusion in treated central retinal vein occlusion as imaged by wide-field fluorescein angiography. Retina. 2011;31(5):829–37.

    PubMed  Google Scholar 

  • Tsui I, Kaines A, Havunjian MA, Hubschman S, Heilweil G, Prasad PS, et al. Ischemic index and neovascularization in central retinal vein occlusion. Retina. 2011;31(1):105–10.

    PubMed  Google Scholar 

  • Wykoff CC, Ou WC, Wang R, Brown DM, Cone C, Zamora D, et al. Peripheral laser for recalcitrant macular edema owing to retinal vein occlusion: the WAVE trial. Ophthalmology. 2017;124(6):919–21.

    PubMed  Google Scholar 

  • Zhou JQ, Xu L, Wang S, Wang YX, You QS, Tu Y, et al. The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. Ophthalmology. 2013;120(4):803–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Emory University, Atlanta, GA, USA

    Andrew M. Hendrick

  2. Doheny Image Reading Center, David Geffen School of Medicine, University of California, Los Angeles, CA, USA

    Michael S. Ip

Authors
  1. Andrew M. Hendrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael S. Ip
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael S. Ip .

Editor information

Editors and Affiliations

  1. New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA

    Alan Sheyman

  2. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Amani A. Fawzi

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hendrick, A.M., Ip, M.S. (2020). Central Retinal Vein Occlusion. In: Sheyman, A., Fawzi, A.A. (eds) Retinal Vascular Disease. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-15-4075-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-4075-2_4

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-4074-5

  • Online ISBN: 978-981-15-4075-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation